Product Name:

ERK5-2


Product Number:

ab-nk206-4

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))

Target Alias: BMK; BMK1; BMK1 kinase; ERK4; ERK-5; Extracellular-signal-regulated kinase 5; Kinase ERK5; MAPK7; PRKM7; ENSG00000166484

Product Type Specific: Protein kinase pan-specific antibody

Antibody Code: NK206-4

Antibody Target Type: Pan-specific

Protein UniProt: Q13164

Protein SigNET: Q13164

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human ERK5 (MAPK7) sequence peptide Cat. No.: PE-01AXI95

Antibody Immunogen Sequence: CTRERIKEAIVAEIED

Antibody Immunogen Description: Corresponds to amino acid residues T373 to D387; Post-kinase last alpha-chain

Production Method: Corresponds to amino acid residues T373 to D387; Post-kinase last alpha-chain

Antibody Modification: Protein kinase pan-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 1 µg/ml for immunoblotting

Antibody Potency: Strong immunoreactivity with recombinant human ERK5 on protein dot blots.

Antibody Species Reactivity: Human; Mouse

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 88-115 kDa.

Antibody Specificity: Medium

Antibody Cross Reactivity: No immunoreactivity on protein dot blots with recombinant human ERK1 and ERK2.

Scientific Background: ERK5 (MAPK7) is a protein-serine/threonine kinase of the CMGC group and MAPK family. It is important in controlling a cell's proliferation, differentiation, and cell survival. Phosphorylation of T219 and Y221 by MEK5 (MAP2K5) increases the phosphotransferase activity of ERK5. MEK5 is activated in response to hyperosmolarity, hydrogen peroxide, and epidermal growth factor (EGF). ERK5 may be a tumour requiring protein (TRP). Although there has been no direct linkage of ERK5 to formation of carcinomas in humans in vivo, in vitro ERK5 over-expression has been shown to increase metastasis, and ERK5 inhibition has been shown to inhibit osteosarcoma cell motility. Upregulation of the MEK5 gene has been noted in breast, prostate, and liver cancer.